406 related articles for article (PubMed ID: 38275523)
1. Rethinking Clozapine: Lights and Shadows of a Revolutionary Drug.
Dell'Osso L; Bonelli C; Nardi B; Giovannoni F; Pronestì C; Cremone IM; Amatori G; Pini S; Carpita B
Brain Sci; 2024 Jan; 14(1):. PubMed ID: 38275523
[TBL] [Abstract][Full Text] [Related]
2. Clozapine's critical role in treatment resistant schizophrenia: ensuring both safety and use.
Remington G; Lee J; Agid O; Takeuchi H; Foussias G; Hahn M; Fervaha G; Burton L; Powell V
Expert Opin Drug Saf; 2016 Sep; 15(9):1193-203. PubMed ID: 27207070
[TBL] [Abstract][Full Text] [Related]
3. Medical management of patients on clozapine: A guide for internists.
Lundblad W; Azzam PN; Gopalan P; Ross CA
J Hosp Med; 2015 Aug; 10(8):537-43. PubMed ID: 25809850
[TBL] [Abstract][Full Text] [Related]
4. Overcoming clozapine's adverse events: a narrative review of systematic reviews and meta-analyses.
Tanzer T; Pham B; Warren N; Barras M; Kisely S; Siskind D
Expert Opin Drug Saf; 2024 Jun; ():1-21. PubMed ID: 38814794
[TBL] [Abstract][Full Text] [Related]
5. Clozapine-Related Myocarditis and Rechallenge: A Case Series and Clinical Review.
Noël MC; Powell V; Burton L; Panda R; Remington G
J Clin Psychopharmacol; 2019; 39(4):380-385. PubMed ID: 31205188
[TBL] [Abstract][Full Text] [Related]
6. Guide to the Management of Clozapine-Related Tolerability and Safety Concerns.
Citrome L; McEvoy JP; Saklad SR
Clin Schizophr Relat Psychoses; 2016; 10(3):163-177. PubMed ID: 27732102
[TBL] [Abstract][Full Text] [Related]
7. Clozapine: balancing safety with superior antipsychotic efficacy.
Meltzer HY
Clin Schizophr Relat Psychoses; 2012 Oct; 6(3):134-44. PubMed ID: 23006238
[TBL] [Abstract][Full Text] [Related]
8. Update on the adverse effects of clozapine: focus on myocarditis.
De Berardis D; Serroni N; Campanella D; Olivieri L; Ferri F; Carano A; Cavuto M; Martinotti G; Cicconetti A; Piersanti M; Saverio Moschetta F; Di Giannantonio M
Curr Drug Saf; 2012 Feb; 7(1):55-62. PubMed ID: 22663959
[TBL] [Abstract][Full Text] [Related]
9. A systematic review of the evidence of clozapine's anti-aggressive effects.
Frogley C; Taylor D; Dickens G; Picchioni M
Int J Neuropsychopharmacol; 2012 Oct; 15(9):1351-71. PubMed ID: 22339930
[TBL] [Abstract][Full Text] [Related]
10. A Guide to the Management of Clozapine-Related Tolerability and Safety Concerns.
Citrome L; McEvoy JP; Saklad SR
Clin Schizophr Relat Psychoses; 2016 Jul; ():. PubMed ID: 27454214
[TBL] [Abstract][Full Text] [Related]
11. A systematic review of clozapine's effectiveness for primary psychotic and bipolar disorders in older adults.
Renzenbrink M; Wand APF
Int Psychogeriatr; 2022 Oct; 34(10):875-887. PubMed ID: 33612141
[TBL] [Abstract][Full Text] [Related]
12. Clozapine in elderly psychiatric patients: tolerability, safety, and efficacy.
Barak Y; Wittenberg N; Naor S; Kutzuk D; Weizman A
Compr Psychiatry; 1999; 40(4):320-5. PubMed ID: 10428193
[TBL] [Abstract][Full Text] [Related]
13. The expanding indications for clozapine.
Young CR; Longhurst JG; Bowers MB; Mazure CM
Exp Clin Psychopharmacol; 1997 Aug; 5(3):216-34. PubMed ID: 9260069
[TBL] [Abstract][Full Text] [Related]
14. Seizure associated with clozapine: incidence, etiology, and management.
Williams AM; Park SH
CNS Drugs; 2015 Feb; 29(2):101-11. PubMed ID: 25537107
[TBL] [Abstract][Full Text] [Related]
15. Unique Effects of Clozapine: A Pharmacological Perspective.
Khokhar JY; Henricks AM; Sullivan EDK; Green AI
Adv Pharmacol; 2018; 82():137-162. PubMed ID: 29413518
[TBL] [Abstract][Full Text] [Related]
16. [Ten years of clinical experience with clozapine about 170 patients].
Levoyer D; Martinet JP; Badiche A; Millet B
Encephale; 2004; 30(3):285-95. PubMed ID: 15235527
[TBL] [Abstract][Full Text] [Related]
17. Clozapine: current status and role in the pharmacotherapy of schizophrenia.
Remington GJ; Addington D; Collins EJ; Jones BD; Lalonde P; MacCrimmon DJ; MacEwan GW
Can J Psychiatry; 1996 Apr; 41(3):161-6. PubMed ID: 8722645
[TBL] [Abstract][Full Text] [Related]
18. Second to none: rationale, timing, and clinical management of clozapine use in schizophrenia.
Qubad M; Bittner RA
Ther Adv Psychopharmacol; 2023; 13():20451253231158152. PubMed ID: 36994117
[TBL] [Abstract][Full Text] [Related]
19. Off-Label Use of Clozapine in Children and Adolescents-A Literature Review.
Rachamallu V; Elberson BW; Vutam E; Aligeti M
Am J Ther; 2019; 26(3):e406-e416. PubMed ID: 31082865
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
